Anti-inflammatory meds: Cost to Your Health - Infection, Cancer

Something that needs to be studied more carefully is the role of inflammation in fighting disease, and the objectionable practice of taking pills to stop inflammation.

The body sits happily at 36.9 degrees Celsius or so.  When we get a bug, this may result in fever.

Now here's where the nosy docs and pharma folk come along.  The thing a physician needs to do, to justify getting paid, is rarely fix the root of a problem, but more than anything to help mitigate pain.  To show change.  If you are hot, you must be cooled, they think.  If cool, warm you up.  This is how a magician convinces his audience of his skill, by showing change, most of all.

Now here's where real science seems to be in short order in medicine.  Every biology student knows bugs multiply best in the temperature range natural to their host - this is an adaptation.  The host too, has adapted to invasion, over eons, with a very simple but effective tool:  fever.  Fever takes the bug out of its optimal range and it must slow down to compensate.  During the break the body sends white blood cells and antibodies to remove the invader.

Bringing inflammation down after a wound or infection is exactly the opposite of what you need.  It stops the temperature rise which in effect cooks the bugs, plus it stops the immune system from deploying cytokines and other immune keys to make a pathway to healing.

The reality is, if one takes these pills too often, not only could one get liver damage, but the ongoing power of the immune system, which keeps down infection and cancer, could be compromised.

What is needed is a hard reset from pharma and their limited scope on disease.  It has been shown in the BMJ that Tylenol, even a single dose, results in 25% higher incidence of asthma, up to 5 years after, in children.  The body exists in a state of delicate balance.  Disrupting this state is provably dangerous, and likely responsible for untold numbers of illnesses and deaths, due to infection and cancer in the immunocompromised state resulting from anti-inflammatory meds.